Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma

Published:2015-08 Issue:2 Volume:194 Page:310-315
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Chevinsky Michael¹,Imnadze Mariam¹,Sankin Alexander¹,Winer Andrew¹,Mano Roy¹,Jakubowski Christopher¹,Mashni Joseph¹,Sjoberg Daniel D.²,Chen Ying-Bei³,Tickoo Satish K.³,Reuter Victor E.³,Hakimi A. Ari¹,Russo Paul¹

Affiliation:

1. Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York

2. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

3. Surgical Pathology Diagnostic Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. SEER Cancer Statistics Review, 1975-2010. Based on November 2012 SEER data submission, posted to the SEER web site, April 2013;Howlader,2013

2. AJCC Cancer Staging Manual;Edge,2010

3. Accuracy of the revised 2010 TNM classification in predicting the prognosis of patients treated for renal cell cancer in the north east of England;Veeratterapillay;J Clin Pathol,2012

4. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?;Thompson;J Urol,2005

5. Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases;Feifer;J Urol,2011

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Nomogram for Predicting Postoperative Recurrence-Free Survival in Patients With Nonmetastatic Pathological T3a Stage Renal Cell Carcinoma;Clinical Genitourinary Cancer;2024-12

2. Development and validation of a nomogram to predict recurrence for clinical T1/2 clear cell renal cell carcinoma patients after nephrectomy;BMC Surgery;2024-06-26

3. Gross Hematuria Does not Affect the Selection of Nephrectomy Types for Clinical Stage 1 Clear Cell Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study;Annals of Surgical Oncology;2024-02-08

4. Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy;Urologic Oncology: Seminars and Original Investigations;2023-09

5. Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis;Asian Journal of Surgery;2023-09